FOXO Stock Overview
FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
FOXO Technologies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.28 |
| 52 Week High | US$5.28 |
| 52 Week Low | US$0.25 |
| Beta | 1.76 |
| 1 Month Change | -19.29% |
| 3 Month Change | 0.86% |
| 1 Year Change | -92.94% |
| 3 Year Change | -99.71% |
| 5 Year Change | n/a |
| Change since IPO | -99.72% |
Recent News & Updates
Recent updates
Shareholder Returns
| FOXO | US Software | US Market | |
|---|---|---|---|
| 7D | 5.8% | 2.5% | 2.9% |
| 1Y | -92.9% | 35.0% | 22.2% |
Return vs Industry: FOXO underperformed the US Software industry which returned 33.9% over the past year.
Return vs Market: FOXO underperformed the US Market which returned 21.9% over the past year.
Price Volatility
| FOXO volatility | |
|---|---|
| FOXO Average Weekly Movement | 14.6% |
| Software Industry Average Movement | 8.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FOXO's share price has been volatile over the past 3 months.
Volatility Over Time: FOXO's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 4 | Mark White | foxotechnologies.com |
FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging.
FOXO Technologies Inc. Fundamentals Summary
| FOXO fundamental statistics | |
|---|---|
| Market cap | US$2.53m |
| Earnings (TTM) | -US$43.38m |
| Revenue (TTM) | US$453.00k |
5.6x
P/S Ratio-0.1x
P/E RatioIs FOXO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FOXO income statement (TTM) | |
|---|---|
| Revenue | US$453.00k |
| Cost of Revenue | US$414.00k |
| Gross Profit | US$39.00k |
| Other Expenses | US$43.42m |
| Earnings | -US$43.38m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.85 |
| Gross Margin | 8.61% |
| Net Profit Margin | -9,576.38% |
| Debt/Equity Ratio | -42.8% |
How did FOXO perform over the long term?
See historical performance and comparison